Psyence Biomedical Ltd.
PBM
$1.75
$0.1710.86%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.94M | -1.46M | 1.01M | -22.79M | -46.59M |
| Total Depreciation and Amortization | 5.00K | 4.60K | 4.20K | 3.10K | 2.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 53.80K | -2.16M | -4.36M | 20.20M | 44.76M |
| Change in Net Operating Assets | -365.00K | -375.60K | -386.20K | -713.30K | -1.04M |
| Cash from Operations | -4.25M | -3.99M | -3.73M | -3.30M | -2.87M |
| Capital Expenditure | -3.60K | -6.70K | -9.80K | -11.00K | -12.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.02M | -2.01M | -6.40K | -3.20K | -- |
| Cash from Investing | -4.02M | -2.02M | -16.20K | -14.20K | -12.20K |
| Total Debt Issued | 0.00 | 500.00K | 1.00M | 1.89M | 2.79M |
| Total Debt Repaid | -- | -- | -- | -75.00K | -150.00K |
| Issuance of Common Stock | 20.40K | 20.40K | 20.40K | 10.20K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 13.47M | 10.80M | 8.13M | 4.85M | 1.58M |
| Cash from Financing | 13.49M | 11.32M | 9.15M | 6.68M | 4.21M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.22M | 5.31M | 5.40M | 3.36M | 1.33M |